| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.539 | 0.024 | 0.539 | Antithrombotic | 0.522 0.026 CID_101235750 | ||
| 0.499 | 0.029 | 0.5 | Immunostimulant | 0.5 0.029 CID_101235750 | CID_101235750 | |
| 0.491 | 0.029 | 0.491 | Vasodilator, peripheral | 0.373 0.064 CID_101235750 | ||
| 0.39 | 0.042 | 0.41 | Spasmolytic | 0.41 0.038 CID_101235750 | CID_101235750 | |
| 0.355 | 0.015 | 0.468 | Thiol protease inhibitor | 0.468 0.011 CID_101235750 | CID_101235750 | |
| 0.369 | 0.034 | 0.372 | Platelet antagonist | 0.372 0.033 CID_101235750 | CID_101235750 | |
| 0.385 | 0.053 | 0.385 | Cholesterol antagonist | 0.362 0.06 CID_101235750 | ||
| 0.336 | 0.009 | 0.336 | Phospholipase A2 inhibitor | 0.329 0.01 CID_101235750 | ||
| 0.353 | 0.033 | 0.355 | Insulysin inhibitor | 0.355 0.032 CID_101235750 | CID_101235750 | |
| 0.364 | 0.049 | 0.364 | Vasodilator, coronary | 0.328 0.067 CID_101235750 | ||
| 0.34 | 0.025 | 0.34 | Anesthetic general | 0.239 0.055 CID_101235750 | ||
| 0.358 | 0.052 | 0.36 | Apoptosis antagonist | 0.36 0.051 CID_101235750 | CID_101235750 | |
| 0.342 | 0.04 | 0.385 | Interleukin antagonist | 0.385 0.033 CID_101235750 | CID_101235750 | |
| 0.348 | 0.047 | 0.405 | Interleukin 2 agonist | 0.405 0.026 CID_101235750 | CID_101235750 | |
| 0.297 | 0.005 | 0.297 | Toll-Like receptor 2 antagonist | 0.272 0.006 CID_101235750 | ||
| 0.314 | 0.024 | 0.333 | Gastrin inhibitor | 0.333 0.015 CID_101235750 | CID_101235750 | |
| 0.304 | 0.018 | 0.354 | Phospholipase C inhibitor | 0.354 0.014 CID_101235750 | CID_101235750 | |
| 0.322 | 0.037 | 0.411 | Psychostimulant | 0.411 0.021 CID_101235750 | CID_101235750 | |
| 0.316 | 0.043 | 0.355 | Angiogenesis stimulant | 0.355 0.031 CID_101235750 | CID_101235750 | |
| 0.31 | 0.043 | 0.43 | Interleukin agonist | 0.43 0.015 CID_101235750 | CID_101235750 | |
| 0.287 | 0.025 | 0.31 | Neuropeptide Y2 antagonist | 0.31 0.015 CID_101235750 | CID_101235750 | |
| 0.348 | 0.088 | 0.365 | Calpain 2 inhibitor | 0.365 0.079 CID_101235750 | CID_101235750 | |
| 0.271 | 0.012 | 0.271 | Cell adhesion inhibitor | 0.268 0.013 CID_101235750 | ||
| 0.291 | 0.034 | 0.291 | Calpain inhibitor | 0.286 0.038 CID_101235750 | ||
| 0.306 | 0.05 | 0.306 | Antiamyloidogenic | 0.269 0.063 CID_101235750 | ||
| 0.296 | 0.047 | 0.329 | 5 Hydroxytryptamine uptake stimulant | 0.329 0.032 CID_101235750 | CID_101235750 | |
| 0.253 | 0.021 | 0.312 | Nav1.2 sodium channel blocker | 0.312 0.014 CID_101235750 | CID_101235750 | |
| 0.224 | 0.004 | 0.224 | Interleukin 1 beta converting enzyme inhibitor | 0.203 0.005 CID_101235750 | ||
| 0.258 | 0.041 | 0.303 | Growth hormone agonist | 0.303 0.032 CID_101235750 | CID_101235750 | |
| 0.223 | 0.007 | 0.223 | Caspase 3 inhibitor | 0.207 0.008 CID_101235750 | ||
| 0.338 | 0.126 | 0.342 | 5 Hydroxytryptamine release inhibitor | 0.342 0.122 CID_101235750 | CID_101235750 | |
| 0.315 | 0.106 | 0.339 | Immunosuppressant | 0.339 0.092 CID_101235750 | CID_101235750 | |
| 0.216 | 0.008 | 0.229 | Folate antagonist | 0.229 0.006 CID_101235750 | CID_101235750 | |
| 0.22 | 0.014 | 0.22 | Cathepsin G inhibitor | 0.172 0.018 CID_101235750 | ||
| 0.218 | 0.021 | 0.226 | Catenin beta inhibitor | 0.226 0.018 CID_101235750 | CID_101235750 | |
| 0.234 | 0.038 | 0.261 | Thrombolytic | 0.261 0.031 CID_101235750 | CID_101235750 | |
| 0.208 | 0.014 | 0.239 | Catalase inhibitor | 0.239 0.01 CID_101235750 | CID_101235750 | |
| 0.285 | 0.091 | 0.338 | Immunomodulator | 0.338 0.064 CID_101235750 | CID_101235750 | |
| 0.207 | 0.016 | 0.207 | Cyclooxygenase 3 inhibitor | 0.184 0.025 CID_101235750 | ||
| 0.212 | 0.029 | 0.213 | Neurotensin receptor agonist | 0.213 0.029 CID_101235750 | CID_101235750 | |
| 0.303 | 0.122 | 0.303 | Histamine release inhibitor | 0.293 0.127 CID_101235750 | ||
| 0.238 | 0.058 | 0.238 | Platelet aggregation inhibitor | 0.191 0.088 CID_101235750 | ||
| 0.214 | 0.04 | 0.243 | Antipruritic | 0.243 0.027 CID_101235750 | CID_101235750 | |
| 0.225 | 0.051 | 0.227 | Insulin sensitizer | 0.227 0.05 CID_101235750 | CID_101235750 | |
| 0.182 | 0.011 | 0.182 | Cell adhesion molecule inhibitor | 0.175 0.012 CID_101235750 | ||
| 0.216 | 0.048 | 0.228 | Anticoagulant | 0.228 0.044 CID_101235750 | CID_101235750 | |
| 0.329 | 0.164 | 0.329 | Caspase 9 stimulant | 0.287 0.209 CID_101235750 | ||
| 0.216 | 0.06 | 0.216 | Non-steroidal antiinflammatory agent | 0.216 0.059 CID_101235750 | ||
| 0.184 | 0.04 | 0.239 | Bone formation stimulant | 0.239 0.027 CID_101235750 | CID_101235750 | |
| 0.218 | 0.078 | 0.257 | Peptidyltransferase inhibitor | 0.257 0.046 CID_101235750 | CID_101235750 | |
| 0.193 | 0.055 | 0.21 | Succinate dehydrogenase inhibitor | 0.21 0.041 CID_101235750 | CID_101235750 | |
| 0.136 | 0.005 | 0.171 | Cholecystokinin antagonist | 0.171 0.005 CID_101235750 | CID_101235750 | |
| 0.218 | 0.091 | 0.218 | Vasodilator | 0.192 0.111 CID_101235750 | ||
| 0.171 | 0.045 | 0.185 | Histone deacetylase SIRT1 inhibitor | 0.185 0.037 CID_101235750 | CID_101235750 | |
| 0.137 | 0.015 | 0.152 | Glutathione S-transferase inhibitor | 0.152 0.011 CID_101235750 | CID_101235750 | |
| 0.128 | 0.009 | 0.179 | Phosphorylase inhibitor | 0.179 0.006 CID_101235750 | CID_101235750 | |
| 0.13 | 0.012 | 0.13 | Toll-Like receptor 2 agonist | 0.129 0.012 CID_101235750 | ||
| 0.247 | 0.131 | 0.266 | Sodium/bile acid cotransporter inhibitor | 0.266 0.112 CID_101235750 | CID_101235750 | |
| 0.116 | 0.004 | 0.116 | Integrin alpha4beta1 antagonist | 0.108 0.004 CID_101235750 | ||
| 0.165 | 0.052 | 0.165 | Hemostatic | 0.159 0.058 CID_101235750 | ||
| 0.155 | 0.043 | 0.155 | Proteasome inhibitor | 0.143 0.05 CID_101235750 | ||
| 0.144 | 0.035 | 0.144 | Photosensitizer | 0.12 0.058 CID_101235750 | ||
| 0.134 | 0.027 | 0.14 | Factor V inhibitor | 0.14 0.023 CID_101235750 | CID_101235750 | |
| 0.113 | 0.007 | 0.141 | Cholecystokinin A antagonist | 0.141 0.005 CID_101235750 | CID_101235750 | |
| 0.146 | 0.042 | 0.147 | Vanilloid 1 agonist | 0.147 0.041 CID_101235750 | CID_101235750 | |
| 0.167 | 0.063 | 0.219 | Diuretic | 0.219 0.038 CID_101235750 | CID_101235750 | |
| 0.134 | 0.034 | 0.134 | Gastric antisecretory | 0.109 0.054 CID_101235750 | ||
| 0.105 | 0.012 | 0.234 | Glycine transporter 2 inhibitor | 0.234 0.005 CID_101235750 | CID_101235750 | |
| 0.133 | 0.042 | 0.142 | Nav1.4 sodium channel blocker | 0.142 0.037 CID_101235750 | CID_101235750 | |
| 0.228 | 0.137 | 0.24 | Ca(v)3.3 blocker | 0.24 0.117 CID_101235750 | CID_101235750 | |
| 0.108 | 0.017 | 0.128 | NMDA receptor agonist | 0.128 0.011 CID_101235750 | CID_101235750 | |
| 0.111 | 0.024 | 0.125 | Vanilloid agonist | 0.125 0.016 CID_101235750 | CID_101235750 | |
| 0.139 | 0.053 | 0.157 | Histone deacetylase class III inhibitor | 0.157 0.039 CID_101235750 | CID_101235750 | |
| 0.14 | 0.055 | 0.14 | Nav1.3 sodium channel blocker | 0.125 0.069 CID_101235750 | ||
| 0.139 | 0.054 | 0.139 | Anesthetic local | 0.105 0.079 CID_101235750 | ||
| 0.136 | 0.058 | 0.164 | Cathepsin H inhibitor | 0.164 0.037 CID_101235750 | CID_101235750 | |
| 0.106 | 0.03 | 0.136 | Hematopoietic | 0.136 0.017 CID_101235750 | CID_101235750 | |
| 0.093 | 0.016 | 0.097 | Caspase 9 inhibitor | 0.097 0.015 CID_101235750 | CID_101235750 | |
| 0.101 | 0.025 | 0.121 | Sphingosine 1-phosphate receptor 4 agonist | 0.121 0.016 CID_101235750 | CID_101235750 | |
| 0.09 | 0.018 | 0.113 | Integrin antagonist | 0.113 0.014 CID_101235750 | CID_101235750 | |
| 0.168 | 0.096 | 0.168 | Amyloid beta aggregation inhibitor | 0.158 0.102 CID_101235750 | ||
| 0.11 | 0.042 | 0.117 | Lanosterol 14 alpha demethylase inhibitor | 0.117 0.034 CID_101235750 | CID_101235750 | |
| 0.138 | 0.071 | 0.154 | Neurotrophic factor | 0.154 0.055 CID_101235750 | CID_101235750 | |
| 0.123 | 0.058 | 0.171 | Interleukin 8 antagonist | 0.171 0.023 CID_101235750 | CID_101235750 | |
| 0.09 | 0.028 | 0.099 | Glucagon-like peptide 1 agonist | 0.099 0.023 CID_101235750 | CID_101235750 | |
| 0.118 | 0.056 | 0.118 | Chelator | 0.118 0.055 CID_101235750 | ||
| 0.087 | 0.025 | 0.126 | Phospholipase D inhibitor | 0.126 0.005 CID_101235750 | CID_101235750 | |
| 0.066 | 0.009 | 0.066 | Plasmepsin II inhibitor | 0.053 0.016 CID_101235750 | ||
| 0.184 | 0.129 | 0.184 | Hypoglycemic | 0.18 0.133 CID_101235750 | ||
| 0.073 | 0.019 | 0.081 | Bombesin 2 receptor antagonist | 0.081 0.017 CID_101235750 | CID_101235750 | |
| 0.147 | 0.093 | 0.17 | Interleukin 6 antagonist | 0.17 0.064 CID_101235750 | CID_101235750 | |
| 0.091 | 0.038 | 0.091 | Interferon agonist | 0.085 0.044 CID_101235750 | ||
| 0.06 | 0.008 | 0.083 | Cholecystokinin B antagonist | 0.083 0.005 CID_101235750 | CID_101235750 | |
| 0.145 | 0.095 | 0.147 | Arachidonic acid antagonist | 0.147 0.092 CID_101235750 | CID_101235750 | |
| 0.083 | 0.033 | 0.083 | Elastase 1 inhibitor | 0.079 0.036 CID_101235750 | ||
| 0.076 | 0.027 | 0.079 | Beta 3 adrenoreceptor antagonist | 0.079 0.024 CID_101235750 | CID_101235750 | |
| 0.083 | 0.035 | 0.112 | Vanilloid 4 agonist | 0.112 0.01 CID_101235750 | CID_101235750 | |
| 0.09 | 0.043 | 0.092 | Chymotrypsin inhibitor | 0.092 0.042 CID_101235750 | CID_101235750 | |
| 0.089 | 0.043 | 0.089 | Caspase 7 inhibitor | |||
| 0.085 | 0.04 | 0.098 | GABA aminotransferase inhibitor | 0.098 0.029 CID_101235750 | CID_101235750 | |
| 0.135 | 0.09 | 0.135 | Neuropeptide Y1 antagonist | |||
| 0.061 | 0.017 | 0.094 | Thymidylate synthase inhibitor | 0.094 0.005 CID_101235750 | CID_101235750 | |
| 0.105 | 0.061 | 0.106 | Protease inhibitor | 0.106 0.06 CID_101235750 | CID_101235750 | |
| 0.14 | 0.097 | 0.14 | Melanin inhibitor | |||
| 0.052 | 0.009 | 0.087 | Glucagon receptor antagonist | 0.087 0.005 CID_101235750 | CID_101235750 | |
| 0.106 | 0.064 | 0.137 | Falcipain 3 inhibitor | 0.137 0.043 CID_101235750 | CID_101235750 | |
| 0.065 | 0.023 | 0.069 | Sphingosine 1-phosphate receptor 1 antagonist | 0.069 0.019 CID_101235750 | CID_101235750 | |
| 0.059 | 0.018 | 0.081 | Erythropoietin receptor agonist | 0.081 0.013 CID_101235750 | CID_101235750 | |
| 0.061 | 0.02 | 0.064 | CD45 antagonist | 0.064 0.018 CID_101235750 | CID_101235750 | |
| 0.134 | 0.093 | 0.143 | Adenylate cyclase stimulant | 0.143 0.075 CID_101235750 | CID_101235750 | |
| 0.078 | 0.038 | 0.087 | Selectin antagonist | 0.087 0.033 CID_101235750 | CID_101235750 | |
| 0.061 | 0.022 | 0.061 | Lysophosphatidic acid 3 receptor antagonist | 0.053 0.031 CID_101235750 | ||
| 0.048 | 0.009 | 0.048 | Ceramide glucosyltransferase inhibitor | 0.047 0.009 CID_101235750 | ||
| 0.124 | 0.087 | 0.147 | Sphingosine 1-phosphate receptor 2 antagonist | 0.147 0.045 CID_101235750 | CID_101235750 | |
| 0.068 | 0.031 | 0.068 | Cathepsin E inhibitor | 0.068 0.031 CID_101235750 | ||
| 0.217 | 0.182 | 0.229 | Toll-Like receptor agonist | 0.229 0.169 CID_101235750 | CID_101235750 | |
| 0.072 | 0.036 | 0.072 | Glutamate (mGluR6) antagonist | 0.069 0.041 CID_101235750 | ||
| 0.049 | 0.014 | 0.053 | Glucagon-like peptide 1 receptor antagonist | 0.053 0.011 CID_101235750 | CID_101235750 | |
| 0.058 | 0.023 | 0.068 | Complement C3a chemotactic receptor antagonist | 0.068 0.018 CID_101235750 | CID_101235750 | |
| 0.044 | 0.01 | 0.044 | Benzodiazepine receptor peripheral-type antagonist | 0.043 0.011 CID_101235750 | ||
| 0.186 | 0.154 | 0.199 | Transcription factor STAT3 inhibitor | 0.199 0.135 CID_101235750 | CID_101235750 | |
| 0.058 | 0.026 | 0.058 | Metalloproteinase-3 inhibitor | 0.049 0.034 CID_101235750 | ||
| 0.067 | 0.035 | 0.083 | Prostaglandin F2 alpha antagonist | 0.083 0.021 CID_101235750 | CID_101235750 | |
| 0.05 | 0.018 | 0.05 | Dihydrofolate reductase inhibitor | 0.047 0.023 CID_101235750 | ||
| 0.1 | 0.069 | 0.1 | Toll-Like receptor 4 antagonist | |||
| 0.044 | 0.013 | 0.048 | Integrin alpha1beta1 antagonist | 0.048 0.009 CID_101235750 | CID_101235750 | |
| 0.048 | 0.017 | 0.092 | Factor XIIIa inhibitor | 0.092 0.006 CID_101235750 | CID_101235750 | |
| 0.043 | 0.013 | 0.051 | Integrin alpha4 antagonist | 0.051 0.011 CID_101235750 | CID_101235750 | |
| 0.159 | 0.128 | 0.16 | Hypolipemic | 0.16 0.127 CID_101235750 | CID_101235750 | |
| 0.069 | 0.04 | 0.069 | Beta adrenoreceptor antagonist | 0.059 0.057 CID_101235750 | ||
| 0.044 | 0.016 | 0.045 | VCAM-1 antagonist | 0.045 0.015 CID_101235750 | CID_101235750 | |
| 0.044 | 0.016 | 0.044 | VCAM antagonist | 0.044 0.015 CID_101235750 | ||
| 0.058 | 0.031 | 0.07 | Thromboxane synthase inhibitor | 0.07 0.018 CID_101235750 | CID_101235750 | |
| 0.094 | 0.067 | 0.098 | Sphingomyelinase inhibitor | 0.098 0.062 CID_101235750 | CID_101235750 | |
| 0.055 | 0.028 | 0.071 | Antimetabolite | 0.071 0.021 CID_101235750 | CID_101235750 | |
| 0.04 | 0.014 | 0.054 | Peptide deformylase inhibitor | 0.054 0.009 CID_101235750 | CID_101235750 | |
| 0.031 | 0.005 | 0.031 | Caspase 8 inhibitor | 0.031 0.005 CID_101235750 | ||
| 0.142 | 0.117 | 0.142 | ATPase inhibitor | |||
| 0.085 | 0.061 | 0.085 | Ornithine decarboxylase inhibitor | |||
| 0.084 | 0.06 | 0.084 | Transcription factor NF kappa B stimulant | |||
| 0.033 | 0.011 | 0.033 | Purinergic P2Y12 antagonist | 0.032 0.011 CID_101235750 | ||
| 0.065 | 0.043 | 0.065 | Interferon inducer | 0.061 0.052 CID_101235750 | ||
| 0.092 | 0.07 | 0.092 | Electrolyte absorption antagonist | 0.086 0.083 CID_101235750 | ||
| 0.044 | 0.022 | 0.049 | Membrane dipeptidase inhibitor | 0.049 0.016 CID_101235750 | CID_101235750 | |
| 0.043 | 0.021 | 0.048 | Cholecystokinin B agonist | 0.048 0.017 CID_101235750 | CID_101235750 | |
| 0.077 | 0.055 | 0.077 | Metalloproteinase-2 inhibitor | 0.071 0.064 CID_101235750 | ||
| 0.191 | 0.17 | 0.191 | Thyroid hormone antagonist | |||
| 0.033 | 0.013 | 0.033 | Prostaglandin EP4 antagonist | |||
| 0.045 | 0.025 | 0.051 | Cathepsin L2 inhibitor | 0.051 0.022 CID_101235750 | CID_101235750 | |
| 0.17 | 0.152 | 0.17 | Cardiotonic | |||
| 0.045 | 0.027 | 0.061 | Oxytocin agonist | 0.061 0.016 CID_101235750 | CID_101235750 | |
| 0.036 | 0.018 | 0.036 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.02 CID_101235750 | ||
| 0.066 | 0.049 | 0.084 | Sirtuin 1 inhibitor | 0.084 0.032 CID_101235750 | CID_101235750 | |
| 0.061 | 0.044 | 0.061 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.055 CID_101235750 | ||
| 0.044 | 0.028 | 0.044 | Leukocyte elastase inhibitor | |||
| 0.057 | 0.041 | 0.079 | Cathepsin L inhibitor | 0.079 0.025 CID_101235750 | CID_101235750 | |
| 0.131 | 0.115 | 0.131 | Heat shock protein 70 antagonist | 0.13 0.121 CID_101235750 | ||
| 0.176 | 0.16 | 0.227 | DNA synthesis inhibitor | 0.227 0.086 CID_101235750 | CID_101235750 | |
| 0.048 | 0.034 | 0.052 | GP IIb/IIIa receptor antagonist | 0.052 0.031 CID_101235750 | CID_101235750 | |
| 0.031 | 0.017 | 0.038 | VLA-4 antagonist | 0.038 0.015 CID_101235750 | CID_101235750 | |
| 0.128 | 0.115 | 0.128 | Interferon gamma antagonist | |||
| 0.024 | 0.011 | 0.024 | Cholecystokinin agonist | 0.023 0.011 CID_101235750 | ||
| 0.045 | 0.032 | 0.051 | Neuraminidase (Influenza A) inhibitor | 0.051 0.022 CID_101235750 | CID_101235750 | |
| 0.05 | 0.037 | 0.057 | NMDA 2A receptor antagonist | 0.057 0.031 CID_101235750 | CID_101235750 | |
| 0.044 | 0.032 | 0.049 | Purinergic P2Y antagonist | 0.049 0.027 CID_101235750 | CID_101235750 | |
| 0.028 | 0.017 | 0.032 | Urotensin II agonist | 0.032 0.014 CID_101235750 | CID_101235750 | |
| 0.027 | 0.016 | 0.037 | Kainate receptor 4 antagonist | 0.037 0.01 CID_101235750 | CID_101235750 | |
| 0.02 | 0.009 | 0.02 | Cholecystokinin A agonist | 0.019 0.009 CID_101235750 | ||
| 0.053 | 0.042 | 0.053 | Beta 1 adrenoreceptor antagonist | |||
| 0.052 | 0.041 | 0.075 | Neuropeptide agonist | 0.075 0.033 CID_101235750 | CID_101235750 | |
| 0.08 | 0.069 | 0.086 | Opioid antagonist | 0.086 0.061 CID_101235750 | CID_101235750 | |
| 0.051 | 0.041 | 0.054 | Cathepsin D inhibitor | 0.054 0.038 CID_101235750 | CID_101235750 | |
| 0.028 | 0.018 | 0.049 | LFA antagonist | 0.049 0.005 CID_101235750 | CID_101235750 | |
| 0.052 | 0.042 | 0.057 | Sphingosine 1-phosphate receptor 5 agonist | 0.057 0.03 CID_101235750 | CID_101235750 | |
| 0.054 | 0.045 | 0.054 | Acetyl-CoA transferase 2 inhibitor | 0.054 0.045 CID_101235750 | ||
| 0.048 | 0.039 | 0.048 | Beta 2 adrenoreceptor antagonist | |||
| 0.039 | 0.03 | 0.041 | Integrin alpha5beta1 antagonist | 0.041 0.027 CID_101235750 | CID_101235750 | |
| 0.052 | 0.043 | 0.07 | Epithelial sodium channel blocker | 0.07 0.018 CID_101235750 | CID_101235750 | |
| 0.053 | 0.044 | 0.06 | Cathepsin B inhibitor | 0.06 0.035 CID_101235750 | CID_101235750 | |
| 0.025 | 0.017 | 0.025 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.066 | 0.058 | 0.066 | Calcium channel L-type blocker | |||
| 0.055 | 0.047 | 0.096 | Cannabinoid CB1 receptor agonist | 0.096 0.021 CID_101235750 | CID_101235750 | |
| 0.133 | 0.127 | 0.138 | Platelet adhesion inhibitor | 0.138 0.12 CID_101235750 | CID_101235750 | |
| 0.015 | 0.009 | 0.017 | Integrin alphaVbeta6 antagonist | 0.017 0.007 CID_101235750 | CID_101235750 | |
| 0.038 | 0.033 | 0.044 | Neurokinin 2 agonist | 0.044 0.025 CID_101235750 | CID_101235750 | |
| 0.055 | 0.051 | 0.055 | Gonadotropin-releasing hormone receptor agonist | 0.055 0.052 CID_101235750 | ||
| 0.053 | 0.048 | 0.053 | Prostaglandin EP2 antagonist | |||
| 0.051 | 0.046 | 0.053 | Angiotensin-converting enzyme inhibitor | 0.053 0.041 CID_101235750 | CID_101235750 | |
| 0.054 | 0.05 | 0.06 | Opioid delta receptor antagonist | 0.06 0.046 CID_101235750 | CID_101235750 | |
| 0.018 | 0.014 | 0.018 | Integrin alphaVbeta1 antagonist | 0.018 0.015 CID_101235750 | ||
| 0.029 | 0.025 | 0.032 | Caspase 2 inhibitor | 0.032 0.022 CID_101235750 | CID_101235750 | |
| 0.019 | 0.016 | 0.02 | Integrin alpha4beta7 antagonist | 0.02 0.015 CID_101235750 | CID_101235750 | |
| 0.071 | 0.068 | 0.075 | Sphingosine 1-phosphate receptor antagonist | 0.075 0.057 CID_101235750 | CID_101235750 | |
| 0.081 | 0.079 | 0.083 | Thioredoxin inhibitor | 0.083 0.075 CID_101235750 | CID_101235750 | |
| 0.02 | 0.018 | 0.02 | Elastase 2A inhibitor | |||
| 0.02 | 0.018 | 0.02 | Elastase 2 inhibitor | |||
| 0.054 | 0.052 | 0.055 | Lipocortins synthesis agonist | 0.055 0.049 CID_101235750 | CID_101235750 | |
| 0.049 | 0.048 | 0.049 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.066 | 0.065 | 0.066 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.064 | 0.063 | 0.069 | Thrombin inhibitor | 0.069 0.056 CID_101235750 | CID_101235750 | |
| 0.027 | 0.027 | 0.043 | Lysophosphatidic acid 2 receptor antagonist | 0.043 0.011 CID_101235750 | CID_101235750 | |
| 0.028 | 0.029 | 0.041 | Calcitonin receptor agonist | 0.041 0.02 CID_101235750 | CID_101235750 | |
| 0.017 | 0.018 | 0.024 | Kainate receptor 5 antagonist | 0.024 0.012 CID_101235750 | CID_101235750 | |
| 0.044 | 0.046 | 0.045 | HCV NS3/NS4A protease inhibitor | 0.045 0.043 CID_101235750 | CID_101235750 | |
| 0.04 | 0.043 | 0.044 | Melanocortin antagonist | 0.044 0.037 CID_101235750 | CID_101235750 | |
| 0.05 | 0.054 | 0.051 | Kallikrein 1 inhibitor | 0.051 0.049 CID_101235750 | CID_101235750 | |
| 0.043 | 0.049 | 0.046 | CC chemokine receptor 2B antagonist | 0.046 0.039 CID_101235750 | CID_101235750 | |
| 0.08 | 0.086 | 0.089 | ABCA1 expression enhancer | 0.089 0.067 CID_101235750 | CID_101235750 | |
| 0.038 | 0.043 | 0.043 | AICAR transformylase inhibitor | 0.043 0.033 CID_101235750 | CID_101235750 | |
| 0.014 | 0.019 | 0.016 | Kainate receptor 3 antagonist | 0.016 0.013 CID_101235750 | CID_101235750 | |
| 0.042 | 0.048 | 0.073 | Ribonucleotide reductase inhibitor | 0.073 0.029 CID_101235750 | CID_101235750 | |
| 0.043 | 0.05 | 0.056 | Thromboxane antagonist | 0.056 0.036 CID_101235750 | CID_101235750 | |
| 0.039 | 0.05 | 0.068 | Ribonucleoside-diphosphate reductase inhibitor | 0.068 0.03 CID_101235750 | CID_101235750 | |
| 0.025 | 0.037 | 0.056 | Kainate receptor 2 antagonist | 0.056 0.013 CID_101235750 | CID_101235750 | |
| 0.031 | 0.043 | 0.039 | Neurokinin 2 antagonist | 0.039 0.031 CID_101235750 | CID_101235750 | |
| 0.035 | 0.051 | 0.049 | Thromboxane A2 antagonist | 0.049 0.037 CID_101235750 | CID_101235750 | |
| 0.05 | 0.066 | 0.058 | Opioid mu receptor antagonist | 0.058 0.056 CID_101235750 | CID_101235750 | |
| 0.018 | 0.037 | 0.027 | AMPA 2 receptor antagonist | 0.027 0.024 CID_101235750 | CID_101235750 | |
| 0.173 | 0.192 | 0.2 | Tyrosine 3 hydroxylase inhibitor | 0.2 0.135 CID_101235750 | CID_101235750 | |
| 0.01 | 0.032 | 0.017 | Thromboxane A2 agonist | 0.017 0.009 CID_101235750 | CID_101235750 | |
| 0.028 | 0.051 | 0.035 | Integrin alpha2 antagonist | 0.035 0.03 CID_101235750 | CID_101235750 | |
| 0.017 | 0.041 | 0.031 | Lysine carboxypeptidase inhibitor | 0.031 0.015 CID_101235750 | CID_101235750 | |
| 0.045 | 0.069 | 0.059 | Sphingosine 1-phosphate receptor 3 antagonist | 0.059 0.039 CID_101235750 | CID_101235750 | |
| 0.07 | 0.094 | 0.137 | Aminopeptidase B inhibitor | 0.137 0.044 CID_101235750 | CID_101235750 | |
| 0.103 | 0.13 | 0.134 | Cell wall synthesis inhibitor | 0.134 0.081 CID_101235750 | CID_101235750 | |
| 0.053 | 0.08 | 0.065 | Potassium channel large-conductance Ca-activated activator | 0.065 0.051 CID_101235750 | CID_101235750 | |
| 0.071 | 0.098 | 0.086 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.066 CID_101235750 | CID_101235750 | |
| 0.011 | 0.042 | 0.041 | AMPA 1 receptor antagonist | 0.041 0.014 CID_101235750 | CID_101235750 | |
| 0.043 | 0.074 | 0.055 | Botulinum neurotoxin type A inhibitor | 0.055 0.046 CID_101235750 | CID_101235750 | |
| 0.058 | 0.09 | 0.074 | MDM2 inhibitor | 0.074 0.029 CID_101235750 | CID_101235750 | |
| 0.016 | 0.051 | 0.037 | Arginase inhibitor | 0.037 0.025 CID_101235750 | CID_101235750 | |
| 0.005 | 0.041 | 0.011 | Integrin beta2 antagonist | 0.011 0.01 CID_101235750 | CID_101235750 | |
| 0.014 | 0.052 | 0.033 | AMPA 3 receptor antagonist | 0.033 0.018 CID_101235750 | CID_101235750 | |
| 0.07 | 0.109 | 0.082 | Estrogen-related receptor beta agonist | 0.082 0.062 CID_101235750 | CID_101235750 | |
| 0.016 | 0.055 | 0.022 | ICAM 1 antagonist | 0.022 0.019 CID_101235750 | CID_101235750 | |
| 0.062 | 0.102 | 0.078 | GABA B receptor agonist | 0.078 0.046 CID_101235750 | CID_101235750 | |
| 0.019 | 0.065 | 0.043 | Kainate receptor antagonist | 0.043 0.026 CID_101235750 | CID_101235750 | |
| 0.019 | 0.069 | 0.037 | Cathepsin L1 inhibitor | 0.037 0.03 CID_101235750 | CID_101235750 | |
| 0.09 | 0.144 | 0.106 | Sphingosine 1-phosphate receptor 2 agonist | 0.106 0.084 CID_101235750 | CID_101235750 | |
| 0.05 | 0.104 | 0.07 | Glutamate dehydrogenase inhibitor | 0.07 0.056 CID_101235750 | CID_101235750 | |
| 0.026 | 0.081 | 0.041 | AMPA 4 receptor antagonist | 0.041 0.024 CID_101235750 | CID_101235750 | |
| 0.023 | 0.084 | 0.04 | Sphingosine 1-phosphate receptor 1 agonist | 0.04 0.033 CID_101235750 | CID_101235750 | |
| 0.024 | 0.089 | 0.065 | Ornithine carbamoyltransferase inhibitor | 0.065 0.029 CID_101235750 | CID_101235750 | |
| 0.031 | 0.098 | 0.076 | NMDA 2C receptor antagonist | 0.076 0.028 CID_101235750 | CID_101235750 | |
| 0.155 | 0.227 | 0.193 | Transcription factor STAT inhibitor | 0.193 0.148 CID_101235750 | CID_101235750 | |
| 0.051 | 0.123 | 0.08 | NMDA receptor antagonist | 0.08 0.065 CID_101235750 | CID_101235750 | |
| 0.066 | 0.14 | 0.103 | Adenylate cyclase inhibitor | 0.103 0.082 CID_101235750 | CID_101235750 | |
| 0.06 | 0.136 | 0.091 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.091 0.064 CID_101235750 | CID_101235750 | |
| 0.095 | 0.171 | 0.125 | Insulin secretagoues | 0.125 0.103 CID_101235750 | CID_101235750 | |
| 0.036 | 0.122 | 0.054 | Sphingosine kinase inhibitor | 0.054 0.051 CID_101235750 | CID_101235750 | |
| 0.04 | 0.129 | 0.074 | Aminopeptidase I inhibitor | 0.074 0.048 CID_101235750 | CID_101235750 | |
| 0.055 | 0.144 | 0.082 | Prolactin inhibitor | 0.082 0.078 CID_101235750 | CID_101235750 | |
| 0.038 | 0.13 | 0.068 | Glutamate decarboxylase inhibitor | 0.068 0.057 CID_101235750 | CID_101235750 | |
| 0.123 | 0.241 | 0.172 | Superoxide dismutase inhibitor | 0.172 0.152 CID_101235750 | CID_101235750 | |
| 0.063 | 0.187 | 0.123 | Alpha-N-acetylglucosaminidase inhibitor | 0.123 0.075 CID_101235750 | CID_101235750 | |
| 0.067 | 0.191 | 0.113 | Aldehyde dehydrogenase inhibitor | 0.113 0.079 CID_101235750 | CID_101235750 | |
| 0.09 | 0.23 | 0.148 | Aldehyde oxidase inhibitor | 0.148 0.141 CID_101235750 | CID_101235750 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |